Heightened SPM receptor levels were also accompanied by increased hippocampal levels of 15-LOX2, a key enzyme in LXA4 biosynthesis; PPARγ, a nuclear receptor involved in SPM action; and reduced anti-inflammatory cytokine IL-10 in AD brains as compared to controls. This evidence concerns the gene PPARG and Alzheimer disease.